Key result
This personal perspective reviews the historical evolution of heart failure treatments, highlighting the development and pivotal trials of ACE inhibitors, ARBs, beta-blockers, and MRAs.
A personal historical perspective on the evolution of foundational heart failure therapies, including ACE inhibitors, ARBs, beta-blockers, and MRAs.
Answers are grounded in this paper and cite their sources.
Offers historical perspective on established HF therapies; leaves open integration with contemporary evidence and novel agents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
John J.V. McMurray (2015) conducted a review in Heart failure. Heart failure therapies (ACE inhibitors, ARBs, beta-blockers, MRAs) was evaluated. This personal perspective reviews the historical evolution of heart failure treatments, highlighting the development and pivotal trials of ACE inhibitors, ARBs, beta-blockers, and MRAs.
Synapse has enriched 10 related papers. Consider them for comparative context: